Document J6pN1E1pyM3X2GXoR1a5oby2

i R3eMguCiloantrotprooyraSSterervoinccesology 31d Sp3MuCtoenorM, XaBuSil5d1in4g 1002020012.6.02 AR226 -- ISR fr BeUp - 20 "273, am Rl *%y Certified Mail 2EHR- 0903_oo `September 8, 2003 " Rl Document Processing Center EPA East -- Room 6428 Attn: Section 8(c) OfficeofPollution Prevention and Toxics US EPA 1200 Pennsylvania A enue NW Washington DC 2046-0001 8 8 32 n 33 2 =a 525 2 RE: TSCA 8(E) SUPPLEMENTAL SUBMISSION: Docket No. SEHQ-0602-00373 Dear Docket Coordintors Conic.+- NO CE. OconmObcitnoebderre3p0e,at2e0d02d,os3eMtopxricoivtiydetedstEwPiAthwrietphrpordeulcitmiivnea/rdyevreesluolptmsefnrtotmoxaicoirtayl screening test for this study on perfluorohexane contains results that sulfonate potassium salt (PFHS). are consistent with the previously The final reported report information. Enclosed please find tae following final report on CD Rom: + Oral (Gavage) Combined Repeated Dose Toxicity StoufTd-77y06 with the Reproductive! developmental Toxicity Screening Test Please contact John Bitenhoff (651-733-1962)ifyou have any questions or ifwe can provide additional information. Sincerely, Kuro n. Joba LaDrirreyctRo.r,JCoohrnpsoornate Toxicology and Regulatory Services Enclosure fii 0008138660 8a on agl 3| Z 22 s 3a5 8a 26479 2 v bec: Cheri Kedrowski - CT&RS ~ 220-2E-02 John Butenhof-f CT&RS - 220-2E-02 | ES